Treatment Planning for Rehabilitation: A Patient-Centered Approach

(12)
Treatment Planning for Rehabilitation: A Patient-Centered Approach image
ISBN-10:

0070778825

ISBN-13:

9780070778825

Edition: Subsequent
Released: Oct 21, 1999
Publisher: APPLETON LANGE
Format: Paperback, 173 pages

Description:

In today's era of cost-containment in health care, clinicians are being forced to maximize the cost-effectiveness of their rehabiitation programs. One method for doing this is enlisting all of the resources available, including the patient. This book goes beyond the patient's family or caregivers) in the process of planning and implementing the goals therapist, and occupational therapist - will find useful advice here. Abundant case studies demonstrate the importance of involving the patient in each stage of the rehabilitation process as a means of improving functional outcomes.

Best prices to buy, sell, or rent ISBN 9780070778825




Frequently Asked Questions about Treatment Planning for Rehabilitation: A Patient-Centered Approach

You can buy the Treatment Planning for Rehabilitation: A Patient-Centered Approach book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $8.99 on Amazon and is available from 7 sellers at the moment.

If you’re interested in selling back the Treatment Planning for Rehabilitation: A Patient-Centered Approach book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Treatment Planning for Rehabilitation: A Patient-Centered Approach book, the best buyback offer comes from and is $ for the book in good condition.

The Treatment Planning for Rehabilitation: A Patient-Centered Approach book is in very low demand now as the rank for the book is 8,427,325 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.